We are live on ! Find out more
JFG

Jefferies Financial Group Portfolio holdings

AUM $14.6B
1-Year Est. Return 40.95%
This Fund
S&P 500
This Quarter Est. Return
+0.66%
1 Year Est. Return
+40.95%
3 Year Est. Return
+104.32%
5 Year Est. Return
+50.55%
10 Year Est. Return
+495.11%
AUM
$14.6B
AUM Growth
-$4.97B
Cap. Flow
-$5.25B
Cap. Flow %
-35.95%
Top 10 Hldgs %
40.16%
Holding
2,315
New
504
Increased
429
Reduced
559
Closed
623

Top Buys

Rank Stock Value
1
XRT icon
State Street SPDR S&P Retail ETF
XRT
+$106M
2
AVGO icon
Broadcom
AVGO
+$103M
3
META icon
Meta Platforms (Facebook)
META
+$90.1M
4
ADP icon
Automatic Data Processing
ADP
+$78.2M
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$74.9M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$365M
2
NVDA icon
NVIDIA
NVDA
+$244M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$223M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$217M
5
CDTX
Cidara Therapeutics
CDTX
+$169M

Sector Composition

Rank Sector Weight
1 Healthcare 8.82%
2 Technology 7.25%
3 Industrials 5.51%
4 Financials 4.33%
5 Consumer Discretionary 3.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
C icon
201
Citigroup
C
$222B
$9.77M 0.07%
86,186
-816,283
-90% -$93M
ADBE icon
202
PUT
Adobe
ADBE
$89.5B
$9.75M 0.07%
+40,100
New +$11.1M
ABCL icon
203
AbCellera Biologics
ABCL
$1.62B
$9.58M 0.07%
+2,746,200
New +$9.88M
ABCL icon
204
PUT
AbCellera Biologics
ABCL
$1.62B
$9.55M 0.07%
+2,736,200
New +$9.84M
TXT icon
205
Textron
TXT
$16.6B
$9.46M 0.06%
108,000
-104,469
-49% -$9.75M
MLTX icon
206
MoonLake Immunotherapeutics
MLTX
$1.59B
$9.32M 0.06%
500,000
– –
COHR icon
207
CALL
Coherent
COHR
$55.2B
$9.31M 0.06%
+39,100
New +$8.95M
ET icon
208
CALL
Energy Transfer Partners
ET
$70.1B
$9.23M 0.06%
+478,000
New +$8.75M
DG icon
209
Dollar General
DG
$25.9B
$9.22M 0.06%
77,686
+70,764
+1,022% +$10.1M
BUR icon
210
Burford Capital
BUR
$907M
$9.17M 0.06%
2,028,743
-474,778
-19% -$4.15M
TTE icon
211
PUT
TotalEnergies
TTE
$193B
$9.1M 0.06%
+100,000
New +$7.64M
GEV icon
212
GE Vernova
GEV
$270B
$9.08M 0.06%
10,407
-30,131
-74% -$23.5M
VIG icon
213
Vanguard Dividend Appreciation ETF
VIG
$111B
$9.01M 0.06%
41,878
-5,067
-11% -$1.13M
GS icon
214
Goldman Sachs
GS
$313B
$8.98M 0.06%
10,610
+5,278
+99% +$4.71M
AAPL icon
215
PUT
Apple
AAPL
$4.89T
$8.86M 0.06%
34,900
-145,100
-81% -$37.8M
CNR
216
CALL
Core Natural Resources Inc
CNR
$4.19B
$8.82M 0.06%
84,200
+64,100
+319% +$6.1M
APLS
217
DELISTED
Apellis Pharmaceuticals
APLS
$8.81M 0.06%
219,000
+210,282
+2,412% +$4.53M
XNCR icon
218
Xencor
XNCR
$1.44B
$8.69M 0.06%
720,440
– –
EOG icon
219
CALL
EOG Resources
EOG
$78B
$8.67M 0.06%
+60,000
New +$7.28M
MTZ icon
220
MasTec
MTZ
$26.7B
$8.64M 0.06%
26,865
-18,182
-40% -$4.92M
ABUS icon
221
Arbutus Biopharma
ABUS
$865M
$8.52M 0.06%
+1,894,067
New +$8.28M
LNG icon
222
PUT
Cheniere Energy
LNG
$56.5B
$8.48M 0.06%
+29,900
New +$6.9M
ALNY icon
223
Alnylam Pharmaceuticals
ALNY
$36.3B
$8.45M 0.06%
25,553
-769
-3% -$262K
TARS icon
224
Tarsus Pharmaceuticals
TARS
$2.56B
$8.33M 0.06%
118,810
– –
ANET icon
225
Arista Networks
ANET
$219B
$8.27M 0.06%
67,342
+49,721
+282% +$6.65M
7 8
9
10 11

Similar funds

HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return

Jefferies Financial Group's Q1 2026 Portfolio in Review

As of Q1 2026, Jefferies Financial Group held 2,315 positions worth $14.6B, down 25% from $19.6B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Jefferies Financial Group withdrew a net $5.25B in Q1 2026, closing 623 positions and reducing 559 holdings. Its most notable exit was Cidara Therapeutics, an estimated $169M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 8.8% of assets, down from 10% a quarter earlier, followed by Technology and Industrials.

Against the trend, Jefferies Financial Group opened a new position in State Street SPDR S&P Retail ETF worth $99M.

  • Jefferies Financial Group's largest Q1 2026 buy was State Street SPDR S&P Retail ETF: 1,230,000 shares worth $99M.
  • Jefferies Financial Group added most to Broadcom in Q1 2026, an estimated $103M increase.
  • Jefferies Financial Group's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $365M.
  • Jefferies Financial Group fully exited Cidara Therapeutics in Q1 2026, selling an estimated $169M.
  • Jefferies Financial Group's ten largest holdings make up 40% of its $14.6B portfolio in Q1 2026.
  • Jefferies Financial Group opened 504 new positions and closed 623 in Q1 2026.
  • Jefferies Financial Group's portfolio value fell 25% quarter-over-quarter to $14.6B.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.